Making Sense of a Complex Landscape
Developers of Medical Diagnostics face a complex and rapidly evolving intellectual property landscape. Successful commercialization of discoveries in this space requires an understanding of:
- The pathway from biomarker to diagnostic tool
- How IP aligns with clinical needs
- Expectations of commercialization partners
This month’s panel features a combination of legal, industry
and tech transfer experts who will share their knowledge of
this unique and important subsector of the life sciences.
MODERATOR:
Patrick J. Kelly, Counsel, Stradley Ronon
PANELISTS:
Rianne Esquivel, PhD, Scientific Affairs Manager, Fujirebio US
James Major, DPhil, Associate, Stradley Ronon
Heather Steinman, PhD, MBA, Vice President for Business Development & Executive Director, Technology Transfer, The Wistar Institute
